LanteRNA

About:

LanteRNA provides nucleic acid label development and drug delivery process services.

Top Investors: Chalmers Ventures AB

Description:

Stealth Labels Biotech includes nucleic acid label development, nucleic acid microscopy or spectroscopy, and comprehension of medication transport mechanisms. The industrial research center for Functional RNA Delivery developed the technology. They offer next-generation nucleotide pharmaceuticals and medication delivery vehicles.

Total Funding Amount:

5.95M SEK

Headquarters Location:

Gothenburg, Vastra Gotaland, Sweden

Founded Date:

2021-01-01

Founders:

Elin Esbjörner Winters, Marcus Wilhelmsson

Number of Employees:

1-10

Last Funding Date:

2024-05-06

IPO Status:

Private

Industries: